跳至主要内容
临床试验/ACTRN12623000039684
ACTRN12623000039684进行中(未招募)未知

CanCommunicate: Efficacy of optimising communication for people with brain cancer and their families with group and individual management sessions

Emma Finch0 个研究点目标入组 40 人开始时间: 2023年1月13日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Aged 18 years or over, diagnosis of primary brain tumour (including benign, lower-grade glioma and higher-grade glioma) which is consistent with the clinical population seen in the multidisciplinary clinic at the recruiting hospital, post-initial cancer treatment, and able to participate in assessment and intervention sessions (with communication support as required).

排除标准

  • Diagnosis other than primary brain cancer (e.g., brain metastases), comorbid substance abuse or psychiatric disorder not effectively managed, or experiencing rapid deterioration in health which limits engagement in the intervention.

研究者

发起方
Emma Finch

相似试验

CanCommunicate: Efficacy of optimising communication... | 临床试验